UQCRC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.498600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.194800E-01
Normal-vs-Stage2
8.626400E-01
Normal-vs-Stage3
5.074400E-01
Normal-vs-Stage4
5.508800E-01
Stage1-vs-Stage2
4.153200E-01
Stage1-vs-Stage3
2.970800E-01
Stage1-vs-Stage4
7.806800E-01
Stage2-vs-Stage3
2.660800E-01
Stage2-vs-Stage4
7.896800E-01
Stage3-vs-Stage4
2.512600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.612200E-01
Normal-vs-AfricanAmerican
5.190600E-01
Normal-vs-Asian
8.807000E-01
Caucasian-vs-AfricanAmerican
3.698000E-01
Caucasian-vs-Asian
6.862600E-01
AfricanAmerican-vs-Asian
3.471200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.107600E-01
Normal-vs-Female
9.934800E-01
Male-vs-Female
6.879200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.033800E-01
Normal-vs-Age(41-60Yrs)
9.070000E-01
Normal-vs-Age(61-80Yrs)
9.921200E-01
Normal-vs-Age(81-100Yrs)
4.818800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.626400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.182400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.813370E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.970400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.427810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.403240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.373200E-01
Normal-vs-Daily Drinker
9.093600E-01
Normal-vs-Weekly Drinker
7.932400E-01
Normal-vs-Occasional Drinker
9.751800E-01
Normal-vs-Social Drinker
8.414000E-01
Non Drinker-vs-Daily Drinker
7.302000E-01
Non Drinker-vs-Weekly Drinker
9.974000E-01
Non Drinker-vs-Occasional Drinker
5.268400E-01
Non Drinker-vs-Social Drinker
3.131400E-01
Daily Drinker-vs-Weekly Drinker
8.019800E-01
Daily Drinker-vs-Occasional Drinker
8.430600E-01
Daily Drinker-vs-Social Drinker
5.858800E-01
Weekly Drinker-vs-Occasional Drinker
6.314800E-01
Weekly Drinker-vs-Social Drinker
4.493000E-01
Occasional Drinker-vs-Social Drinker
6.612600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.287960E-01
Normal-vs-Grade 2
1.538460E-02
Normal-vs-Grade 3
1.161510E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.499000E-03
Grade 1-vs-Grade 3
1.336010E-03
Grade 1-vs-Grade 4
1.287960E-01
Grade 2-vs-Grade 3
4.926000E-01
Grade 2-vs-Grade 4
1.538460E-02
Grade 3-vs-Grade 4
1.161510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.652400E-01
Normal-vs-NonDiabetic
8.821800E-01
Diabetic-vs-NonDiabetic
5.505800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.241400E-01
Normal-vs-NoPancreatitis
9.056000E-01
Pancreatitis-vs-NoPancreatitis
1.088840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.289000E-01
Normal-vs-N1
9.499400E-01
N0-vs-N1
5.329000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.411400E-01
Normal-vs-TP53-NonMutant
9.534800E-01
TP53-Mutant-vs-TP53-NonMutant
1.125380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
